Mitochondrial membrane lipid bilayer

The mitochondrial membrane lipid bilayer consists of the outer and inner membranes, which serve as the primary site for oxidative phosphorylation and cellular respiration (Source: StatPearls, Physiology, Mitochondria). The inner membrane is characterized by a high protein-to-lipid ratio and the presence of the unique phospholipid cardiolipin, which is essential for the assembly of respiratory supercomplexes and the maintenance of the proton motive force (Source: Paradies et al., 2014). Disruption of this lipid environment is a hallmark of mitochondrial diseases, aging, and ischemia-reperfusion injury, often leading to increased reactive oxygen species production and decreased ATP synthesis (Source: NCBI, Mitochondrial Membrane Lipids in Health and Disease). Pharmacological targeting of the bilayer includes the use of small molecules like elamipretide, which binds to cardiolipin to stabilize the membrane and restore mitochondrial energetics (Source: Chavez et al., 2020). Other agents, such as mitochondrial-targeted antioxidants like MitoQ, utilize the electrochemical gradient across the bilayer to accumulate within the matrix and protect the lipid environment from oxidative damage (Source: Murphy, 2008). Because the mitochondrial membrane is central to cell survival, therapeutic interventions must carefully balance the restoration of function against the risk of triggering apoptosis or metabolic collapse.

Other names

Mitochondrial membraneInner mitochondrial membraneOuter mitochondrial membraneMitochondrial lipid envelopeMitochondrial lipid bilayer

Drugs targeting the mitochondrial membrane lipid bilayer typically act by stabilizing specific phospholipids like cardiolipin to maintain cristae structure, modulating membrane permeability to ions, or decoupling the proton gradient to alter metabolic flux (Source: Chavez et al., 2020; Murphy, 2008).